Reimagining medicine in cancer
We have the passion and the people to help transform lives as we pursue treatments for patients.
Core disease areas
At Novartis, we push the limits of science to develop innovative therapies. These therapies have the potential to be new foundations for cancer care in areas with great unmet need.
Novartis aims to tackle breast cancer with bold science, collaboration, and a passion for transforming patient care. We take a bold approach to our research by including patient populations who are often neglected in clinical trials, identifying new pathways or mutations that may play a role in disease progression, and developing therapies to help extend and improve the lives of patients.
We are harnessing the innovation of our world-class scientists, strategic partnerships, and one of the industry’s most competitive pipelines to explore the potential of our targeted therapies to address unmet needs in prostate cancer. Our goal is to reduce the global disease burden, extend the lives of patients with prostate cancer, and elevate current standards of care.
When you think of the word ‘cancer,’ what are the first words that spring to mind?
Fighter. Hero. Cancer-stricken. The words and metaphors people use to talk about cancer often feel worlds apart from any other disease. But how far does it go? Do words matter?
Let’s Talk About The C-Word
Talking about cancer can be challenging. Hear from one patient who was inspired to drive change.
Addressing racial disparities in breast cancer screening
Novartis today announced the launch of More Than JustWords, a multiyear commitment to promote health equity in breast cancer.
Latest cancer news
Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups
Novartis to feature new PNH and CML scientific data from broad hematology portfolio at European Hematology Association Annual Meeting
Novartis to present new data across oncology portfolio including Kisqali Phase III NATALEE trial in early breast cancer at ASCO
Clinical trials and pipeline projects
Find cancer-related clinical trials and learn more about the projects in development around cancer.
Learn more about the other Novartis core therapeutic areas